We are surrounded by bacteria, airborne viruses, spores, and toxins in our daily life.
These pathogens are the main cause of allergies, influenza, respiratory infections, and many other diseases.
For many of these diseases, there is no efficient cure, treatment or vaccine.
These include the H1N1 virus known as the Swine Flu, SARS, MERS and COVID-19.
According to data from the World Health Organization Influenza, with an estimated 1 billion cases across the globe every year, remains one of the world’s greatest public health challenges.
It is predicted that at least 30 new diseases have emerged in the last 20 years.
The MyAirShield Badge with our patented pearls is an advanced device that provides up to 90 days of active air purification to help disinfect your breathing space.
It aids in disinfecting and sanitizing the air around you by spreading an atmospheric shield of low concentrated, solid, CLO2 - one of the best agents against microbial life.
By oxidation, it reacts directly with the cell wall of pathogens, effectively killing both active and inactive pathogens.
Due to its attribute, pathogens are unable to build up any resistance against this disinfectant.
The MyAirShield agent has been tested on various corona virus variants, among others on highly positive Covid-19 samples.
"The MyAirShiled product is antiviral, antibacterials, and antifungal working in different environments."
Tests show that the MyAirShield agent is highly effective against on large variety of airborne pathogens, such as viruses, bacteria and spores.
These tests include those for release rate, toxicity and efficiency - including effectiveness against corona variants.
MyAirShield collaborates with accredited laboratories to ensure a broad and profound testing against international standards. Additionally, independent third-party studies confirm the efficiency.
The MyAirShield testing include studies for release rates and toxicity, proving the MyAirShield Badge is perfect for every day use.
It is registered at ECHA (EU), COFEPRIS (MX) and FDA (US) (as a Class 1 Medical Device).
It may be used in closed and crowded spaces, including hospitals, on public transport, cafés and restaurants, in school, in the office and other public spaces, and even in your own home.
It can be used as an additional disinfectant measure for office staff, elderly people, children and the public in general.
The MyAirShield Badge lanyard is safe to wear due to its safety lock and the adjustable lanyard.
The MyAirShield agent is both tested for efficacy against pathogens and for harmlessness in daily use for humans. This is reflected in three core study areas:
MYAIRSHIELD IN THE LABORATORY
Our patented pearls are an advanced, innovative technology and serve as the agent in the MyAirShield Badge.
To prove its efficacy MyAirShield collaborates with various laboratories and scientists globally.
Independent scientific studies support the findings, in addition to official governmental approvals and registrations.
MyAirShield Pearls© are made up of a mixture of chemical components. These are i.a. Sodium Chlorite (NaClO2), Sodium Chloride (NaCl) and Sodium Carbonate (Na2CO3). They maintain a structure that allows to interact with other components in the air. Our patented technology enables them, i.a. through the reaction with humidity in the air, to release of a low, stable and safe amount of the disinfectant.
The agent penetrates micro-organisms and reacts with their cellular components, oxidizing proteins or nucleic acids, causing them to break down. Human cells are much larger than micro-organisms and thus large quantities of the agent would be needed to damage human cells.
Human cells have the advantage of being able to break down CLO2 into ions which the body uses for everyday physiological processes in turn to prevent its accumulation inside of the cell and thus avoiding damage.
To prove the effectiveness and at the same time the harmlessness to humans, MyAirShield carried out multiple profound testing, according to various standards. Our science department is constantly working on the refinement of the tests, the test results and proof of effectiveness.
The work initially concentrates on the following most important focus areas:
The Release Rate Test provides information of how much of the MyAirShield agent is released within a certain time. Results show that the MyAirShield agent is harmless in an intended every day use.
Conducted studies show a stable slow release of the agent after the badge being activated, lasting or at least 90 days, while concentration levels stay below 100ppb in testing scenarios, and hence way below allowed standards. In the studies, the concentration of the agent builds up linear to a certain point, after which the release rate curve starts to plateau out to a more constant level. The test were done on sealed container conditions, any form of air ventilation would naturally push the maximum concentration further below any legal thresholds. In addition, the agent mixes homogeneously in the air.
Based on received results we can presume the following value for an example scenario:
Room size: 100 m³ (3531 ft³)
Student: 25 / each wearing one MAS Badge
Ventilation: Exchange rate at 2 times per hour
Max. concentration in the air:
0.15ppb at 1,5 hours
(National Institute for Occupational Safety and Health recommend exposure limit of 100ppb (TWA) and 300ppb (STEL))
Toxicity Tests provide information about the toxicity of the MyAirShield ingredients for humans, on oral, inhalation and dermal level. Results show that the MyAirShield agent is harmless in an intended every day use.
To ensure the harmlessness of the MyAirShield Badge for every day use, MyAirShield conducted various toxicity tests in inhalation, oral and dermal studies, among others tests according to OECD-403 (non-corrosive) and OECD-402 (acute dermal toxicity) standards.
Further tests conducted show equally good results.
Efficiency Tests provide information about the efficacy of the MyAirShield agent against specific virus, bacteria and spores. Results show that the MyAirShield agent is very efficacious against tested pathogens, including Corona Virus variants.
MyAirShield conducted extensive Efficiency Tests, proving the efficacy of the agent and the product. The results received prove excellent efficiency against not only most pathogens but also against Corona variants.
Conducted aerosol testing show log 4 reduction against all viruses, bacteria and spores of international standard.
Based on these results the MyAirShield patented technology is registered with ECHA (EU), COFEPRIS (MX) and the FDA (US) (Class1 Medical Device).
Please see the full list of tested pathogens below.
An independent study shows additionally,
"Following gram positive and gram negative microorganisms are tested against MyAirShield pearls with each organism:
Adenovirus, B.Pertussis, C.Pneumoniae, CoV_NL63, CoV_OC43, L.Pneumophila, M.Pneumoniae, mecA, Rhinovirus,
S.Agalactiae, S.Aureus, S.Pneumoniae, Covid-19, Psedomonia, EColi, Candida"
"My Shield product is antiviral, antibacterial, and antifungal working in different environments."
In the scope of the Efficiency Tests the MyAirShield technology were also tested against various Corona variants, among others on highly positive Covid-19 sample (SARS-Cov2) with a CT value of 18 (in experimental status).
Tests were conducted with positive / negative control according to international laboratory standards.
Results show an equal reduction as the studies in the other Efficiency Tests.
OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring - OECD principles of Good Laboratory Practice (as revised in 1997) - Environment Directorate - Organization for Economic Co- Operation and Development, Paris 1998.
Legislative decree n. 50 of March the 2", 2007. Enforcement of Community Directives 2004/9/CE and 2004/10/CE, concerning the inspection and verification of Good Laboratory Practice and the drawing of the legislative, regulatory and administrative dispositions relative to the application of Good Laboratory Practice rules, to the control of their application on the assays performed on the chemical substances (GU n.86of April the 13, 2007).
United States Food and Drug Administration (FDA), Title 21 Code of Federal Regulations Part 58, Federal Register 22 December 1978, and subsequent amendments.
GLP Certification N. 2019/25 released by the Italian Ministry of Health on September 12, 2019 authorizing Eurofins Biolab S.r.l. to perform analyses in compliance with the principles of good laboratory practices
WS/T 206 Methods for the Determination of Inhalable Particulates in Air
in Public Places - Technical Standard for Disinfection 2.1.3, 220.127.116.11, 18.104.22.168 (CN Ministry of Public Health, 2002 edition)
Following test studies have been conducted and are ongoing at multiple third-pary laboratories:
• Efficiency Tests
Proving the efficiency of the MyAirShield Agent against common pathogens like viruses, bacteria, spores.
Standards i.a.: WS/T 206
• Release Tests
Proving the maximum release values of CLO2 from the MyAirShield Batch are compliant with legal limits, thus unharmful for humans.
Standards i.a.: ISO/IEC17025:2005
• Toxicity Tests
Proving that the MyAirShield agent is not harmful for humans, proven in each an oral, inhalation and dermal test.
Standards i.a.: OECD420, OECD431, EPI-200-SCT
• Corona Efficiency Test
Proving the efficiency of the MyAirShield Agent against Corona virus variants.
Tested on most standard pathogens as i.a.
We work under the premise of offering the best possible transparency about us and our product.
For this we offer our partners and potential interested parties all the necessary documentation. In addition, we are constantly working to refine and improve our proofs and certificates.
Our product gets released only to markets with the official approval of the authorities in the respective countries.